Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results...

por Tepper, Stewart J., Ailani, Jessica, Ford, Janet H., Nichols, Russell M., Li, Lily Q., Kemmer, Phebe, Hand, Austin L., Tockhorn-Heidenreich, Antje
Publicado 2022

Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase II...

por Tepper, Stewart J., Ailani, Jessica, Ford, Janet H., Nichols, Russell M., Li, Lily Q., Kemmer, Phebe, Hand, Austin L., Tockhorn-Heidenreich, Antje
Publicado 2022

Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial

por Reuter, Uwe, Lucas, Christian, Dolezil, David, Hand, Austin L., Port, Martha D., Nichols, Russell M., Stroud, Chad, Tockhorn-Heidenreich, Antje, Detke, Holland C.
Publicado 2021

THU035 Impact Of Surgery Or Medical Treatment With The Selective Glucocorticoid Receptor Modulator Relacorilant On Hypercoagulopathy In Patients With Cushing Syndrome

por Simeoli, Chiara, Di Paola, Nicola, Stigliano, Antonio, Lardo, Pina, Kearney, Tara, Mezosi, Emese, Ghigo, Ezio, Giordano, Roberta, Mariash, Cary N, Donegan, Diane, Feelders, Richard A, Hand, Austin L, Moraitis, Andreas G, Pivonello, Rosario
Publicado 2023